Case Report: Stiff Person Syndrome with Thymoma

DOI Web Site 参考文献12件 オープンアクセス
  • Sonokawa Takumi
    Department of Surgery, Sapporo-Kosei General Hospital Department of Thoracic Surgery, Nippon Medical School Hospital
  • Shizukawa Hirohiko
    Department of Neurology, Sapporo-Kosei General Hospital
  • Ichihara Shin
    Department of Pathology, Sapporo-Kosei General Hospital
  • Muraoka Shunji
    Department of Pathology, Sapporo-Kosei General Hospital
  • Usuda Jitsuo
    Department of Thoracic Surgery, Nippon Medical School Hospital
  • Tanaka Koichi
    Department of Surgery, Sapporo-Kosei General Hospital

この論文をさがす

説明

<p>Background. Stiff person syndrome is a rare neurological syndrome characterized by fluctuating muscle rigidity and painful spasms. About 5-8% of stiff person syndrome cases are associated with malignant tumors, and the symptoms can manifest as a paraneoplastic disorder. Case. We herein report a 68-year-old man who was referred to our hospital with a chief complaint of gait disturbance due to painful muscle rigidity in both legs. Examinations of the head and spine showed no abnormalities. However, on chest computed tomography, an anterior mediastinal tumor was seen, and blood tests showed a high titer of anti-glutamic acid decarboxylase antibody. These findings suggested that his symptoms could be attributed to paraneoplastic neurological syndrome associated with the mediastinal tumor. Furthermore, characteristic symptoms and laboratory findings also indicated stiff person syndrome. These symptoms were not affected by initial treatment with steroids, but they were improved by benzodiazepine and baclofen treatment. The pathological diagnosis after radical thymectomy was type B2 thymoma. The patient's postoperative course was uneventful. His medications were decreased, and his symptoms gradually improved. Conclusion. Thymectomy might offer symptomatic relief for stiff person syndrome associated with thymoma.</p>

収録刊行物

  • 肺癌

    肺癌 59 (4), 360-365, 2019-08-20

    特定非営利活動法人 日本肺癌学会

参考文献 (12)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ